The company sells capital markets technology to small banks that have growing international processing needs, betting the ...
As previously reported, Wells Fargo analyst Derek Archila downgraded Septerna (SEPN) to Equal Weight from Overweight with a price target of ...
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $98.00. The ...
U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Non-Cum. Perp. Pfd. Series K) 0.00% U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Perp. 3.75% Pfd. Series L)-0.72% U.S. Bancorp Dep. Pfd ...
Wells Fargo & Co. has satisfied the requirements of a consent order issued by the Consumer Financial Protection Bureau, its seventh resolution since 2019 of a consent order set by federal ...
Wells Fargo offers credit cards for earning rewards, financing purchases or enjoying unique perks like cell phone protection. Cards like the Wells Fargo Autograph Journeyâ„ Card (see rates and ...
uniQure says it has reached an agreement with the FDA on a pathway to accelerated approval for its Huntington's disease gene therapy based on a phase 1/2 trial. The announcement led to a doubling ...
Investing.com -- Shares of Wells Fargo & Company ... While today's stock movement reflects the market's immediate reaction to the regulatory update, Wells Fargo's long-term performance will likely ...
It is widely believed that fund houses often strive to maximize their focus on meeting the high demand for small and midcap investments, even during challenging market conditions. Recent data on ...
4, 2025 — Research has shown that a potential new targeted therapy ... Blood Cell Production Over the Lifetime Could Impact Leukemia Outcomes Dec. 5, 2024 — The first comprehensive map of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results